Open Access

[Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy

  • Authors:
    • Jun Teishima
    • Daiki Murata
    • Shogo Inoue
    • Tetsutaro Hayashi
    • Koji Mita
    • Yasuhisa Hasegawa
    • Masao Kato
    • Mitsuru Kajiwara
    • Masanobu Shigeta
    • Satoshi Maruyama
    • Hiroyuki Moriyama
    • Seiji Fujiwara
  • View Affiliations

  • Published online on: June 10, 2021     https://doi.org/10.3892/mco.2021.2317
  • Article Number: 155
  • Copyright : © Teishima et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Following the publication of the above article, the authors have requested a change in the authorship on the paper. The final author in the author list, Professor Akio Matsubara (of the Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University), contacted the Editorial Office to say that he should not have been listed as an author in this published article. His inclusion as an author on the paper arose as a misunderstanding on the part of some of the other authors. The revised authorship on the paper is shown above, now excluding Akio Matsubara. All the remaining authors agree with the revision made to the authorship on this paper, and the authors remaining on the paper apologize for any inconvenience caused. Therefore, the revised authors’ names and affiliations in this paper are as follows: Jun Teishima1, Daiki Murata2, Shogo Inoue1, Tetsutaro Hayashi1, Koji Mita2, Yasuhisa Hasegawa3, Masao Kato4, Mitsuru Kajiwara5, Masanobu Shigeta6, Satoshi Maruyama7, Hiroyuki Moriyama8 and Seiji Fujiwara9. 1Department of Urology, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734‑8551; 2Department of Urology, Hiroshima‑City Asa Citizens Hospital, Hiroshima 731‑0293; 3Department of Urology, Fukuyama Medical Center, Fukuyama, Hiroshima 720‑8520; 4Department of Urology, Hiroshima General Hospital, Hatsukaichi, Hiroshima 738‑8503; 5Department of Urology, Hiroshima Prefectural Hospital, Hiroshima 734‑8530; 6Department of Urology, Kure Medical Center and Chugoku Cancer Center, Kure, Hiroshima 737‑0023; 7Department of Urology, Miyoshi Central Hospital, Miyoshi, Tokushima 728‑8502; 8Department of Urology, Onomichi General Hospital, Onomichi, Hiroshima 722‑8508; 9Department of Urology, Higashi‑Hiroshima Medical Center, Higashi‑Hiroshima, Hiroshima 739‑0041, Japan. [the original article was published on Molecular and Clinical Oncology 12: 557‑564, 2020; DOI: 10.3892/mco.2020.2020]

Related Articles

Journal Cover

August-2021
Volume 15 Issue 2

Print ISSN: 2049-9450
Online ISSN:2049-9469

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Teishima J, Murata D, Inoue S, Hayashi T, Mita K, Hasegawa Y, Kato M, Kajiwara M, Shigeta M, Maruyama S, Maruyama S, et al: [Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy. Mol Clin Oncol 15: 155, 2021
APA
Teishima, J., Murata, D., Inoue, S., Hayashi, T., Mita, K., Hasegawa, Y. ... Fujiwara, S. (2021). [Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy. Molecular and Clinical Oncology, 15, 155. https://doi.org/10.3892/mco.2021.2317
MLA
Teishima, J., Murata, D., Inoue, S., Hayashi, T., Mita, K., Hasegawa, Y., Kato, M., Kajiwara, M., Shigeta, M., Maruyama, S., Moriyama, H., Fujiwara, S."[Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy". Molecular and Clinical Oncology 15.2 (2021): 155.
Chicago
Teishima, J., Murata, D., Inoue, S., Hayashi, T., Mita, K., Hasegawa, Y., Kato, M., Kajiwara, M., Shigeta, M., Maruyama, S., Moriyama, H., Fujiwara, S."[Corrigendum] Improved prognosis for elderly patients with metastatic renal cell carcinoma in the era of targeted therapy". Molecular and Clinical Oncology 15, no. 2 (2021): 155. https://doi.org/10.3892/mco.2021.2317